(Q84169190)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19576796%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Role of PSA velocity in predicting pathologic upgrade for Gleason 6 prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19576796%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

L Spencer Krane

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19576796%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sanjeev A Kaul

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19576796%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sameer A Siddiqui

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19576796%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Christel Wambi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19576796%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

James O Peabody

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19576796%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

3 July 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19576796%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19576796%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19576796%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19576796%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

372-377

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19576796%20AND%20SRC:MED&resulttype=core&format=json

Prostate cancer volume at biopsy predicts clinically significant upgrading

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

Predicting the risk of patients with biopsy Gleason score 6 to harbor a higher grade cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

Relapse after radical prostatectomy correlates with preoperative PSA velocity and tumor volume: results from a screening population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

PSA velocity is associated with gleason score in radical prostatectomy specimen: marker for prostate cancer aggressiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

Prostate-specific antigen velocity and prostate cancer gleason grade and stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

Active surveillance for the management of prostate cancer in a contemporary cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

Prostate Cancers Scored as Gleason 6 on Prostate Biopsy are Frequently Gleason 7 Tumors at Radical Prostatectomy: Implication on Outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

Histologic grading of prostate cancer: a perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

Preoperative PSA velocity and doubling time do not predict adverse pathologic features or biochemical recurrence after radical prostatectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

Prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

The changing face of low-risk prostate cancer: trends in clinical presentation and primary management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

Improved stage and grade-specific progression-free survival rates after radical prostatectomy in the PSA era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.04.018

10.1016/J.UROLONC.2009.04.018

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19576796%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference